Provider: Directors Deals Ltd.
Provider: ValuEngine, Inc.
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
Straumann Holding Ltd Comments on FY 2013 Guidance
Straumann Holding Ltd announced that its fiscal year 2013 revenue is expected to be at least in-line with the prior fiscal year 2012 in organic terms.
Latest Key Developments in Medical
- Sorin SpA confirms FY 2014 adjusted net profit full-year guidance
- Baxter International's investigational 20 pct Subcutaneous Immunoglobulin Treatment meets efficacy and tolerability endpoints in phase 2/3 Study
- RTI Surgical Inc gives Q4 2014 EPS guidance; revenue guidance above analysts' estimates; raises low end of prior FY 2014 guidance
- MiMedx Group Inc reaffirms Q4, FY 2014, FY 2015 revenue outlook
- Share this
- Digg this